FDA clears Siemens' SieScape technique
Siemens Ultrasound Group in Issaquah, WA, will use momentum generatedwith the 1995 launch of the 256-channel Sonoline Elegra as a springboardto this year's show. Heading the division's new product offeringswill be SieScape, an image-processing technique
Siemens Ultrasound Group in Issaquah, WA, will use momentum generatedwith the 1995 launch of the 256-channel Sonoline Elegra as a springboardto this year's show. Heading the division's new product offeringswill be SieScape, an image-processing technique that allows real-timeimaging of extremely large fields-of-view (SCAN 12/13/95).
With SieScape, a technologist can capture continuous acquisitionscovering nearly unlimited sweeps across the patient's body. Thedisplay pans across the acquisition at standard frame rates andmay be frozen over specific areas of interest. SieScape received510(k) clearance in October.
Also look for Siemens to discuss its Managed Healthcare Servicesdivision, which was formed earlier this year to offer businessconsulting services to radiology departments and hospitals (SCAN5/8/96).
In nuclear medicine, the variable-angle dual-head E.Cam willreprise the starring role it held at the Society of Nuclear Medicinemeeting in June (SCAN 6/5/96). Siemens will emphasize high-energytechniques for the system and plans to begin commercial shipmentsin November.
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Ultrasound-Guided Thermal Ablation Shows Low Recurrence of Thyroid Carcinoma at Five Years
June 16th 2025In a meta-analysis involving over 2,200 patients with T1NoMo papillary thyroid carcinoma, researchers noted 2 percent recurrence and no cases of lymph node metastasis five years after ultrasound-guided thermal ablation.
